FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Abstract Background Selectively targeting leukemia stem cells (LSCs) is a promising approach in treating acute myeloid leukemia (AML), for which identification of such therapeutic targets is critical. Increasing lines of evidence indicate that FBXO22 plays a critical role in solid tumor development...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2023-02-01
|
| Serie: | Journal of Hematology & Oncology |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s13045-023-01400-0 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|